Eastern Bank’s Vera Therapeutics VERA Stock Holding History

Eastern Bank’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.81M	Hold	56,050	–	–	0.03%	166
2026 Q2	$2.41M	Hold	56,050	–	–	0.04%	146
2026 Q1	$2.25M	Hold	56,050	–	–	0.04%	160
2025 Q4	$2.84M	Hold	56,050	–	–	0.05%	128
2025 Q3	$1.63M	Hold	56,050	–	–	0.03%	158
2025 Q2	$1.32M	Hold	56,050	–	–	0.03%	170
2025 Q1	$1.35M	Hold	56,050	–	–	0.03%	187
2024 Q4	$2.37M	Hold	56,050	–	–	0.04%	156
2024 Q3	$2.48M	Buy	+56,050	New	+$2.13M	0.04%	160

Other funds holding VERA

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Eastern Bank's VERA Position: Q3 2026 in Review

Eastern Bank held its Vera Therapeutics (VERA) position steady in Q3 2026 at 56,050 shares worth $1.81M. The position accounts for 0.03% of the portfolio, ranked #166.

Eastern Bank first reported a position in VERA in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.84M in Q4 2025. 71 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

Eastern Bank held 56,050 shares of Vera Therapeutics worth $1.81M as of Q3 2026.
Eastern Bank left its Vera Therapeutics share count unchanged in Q3 2026.
Vera Therapeutics made up 0.03% of Eastern Bank's portfolio in Q3 2026, its #166 holding.
Eastern Bank first reported a position in Vera Therapeutics in Q3 2024 and has held it in 9 quarters since.
Eastern Bank's Vera Therapeutics position peaked at $2.84M in Q4 2025.
71 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.